Eagle IP is pleased to announce that the firm will be relocating its Hong Kong office to Wan Chai: Room 1501, 15/F, 3 Lockhart Road, Wan Chai, Hong Kong.

The move to this new, modern office reflects the firm’s continued growth and commitment to providing an enhanced working environment for our team while maintaining excellent accessibility for clients. Located in the heart of Wan Chai, the new premises offer a more central and convenient location with improved facilities and greater space to better serve our expanding client base.

We look forward to welcoming clients and partners to our new office in Wan Chai in the coming weeks. Our contact numbers, email addresses, and all other communication channels will remain unchanged during and after the relocation.

我們過去活動

Eagle IP to Participate in AIPLA 2026 Spring Meeting in San Francisco

2026年5月8日

Eagle IP has been named as the Winner of the LSPN Cross-Border Collaboration Partner of the Year Award at the LSPN Awards USA 2026

2026年5月8日

Eagle IP to Attend INTA 2026 Annual Meeting in London

2026年5月2日

Eagle IP’s Jennifer Che to Attend LSPN North America Spring 2026 in Boston

2026年4月29日

Pauli Wong to Share IP Strategy Insights at HKLSS Entrepreneurship Series 2026

2026年4月25日

Eagle IP and HKSTP Host AIPLA Women in IP Global Networking Event

2026年4月16日

Recommended Insights

China Releases Draft Implementation Guidelines for the Drug Administration Law

2022年6月2日
The latest draft implementation guidelines for China’s Drug Administration Law (“Guidelines”) are out and open for comment. Previously, the new implementation measures for early dispute resolution mechanisms for drug patents (“Patent Linkage Measures”) came into effect on July 4, 2021. The Guidelines indicate that the final approval of generic chemical drug applications for marketing approval […]
閱讀更多 >

NMPA's Releases Draft Measures for Data Protection (Data Exclusivity)

2025年9月4日
In March 2025, China's National Medical Products Administration (NMPA) released yet another set of draft implementation measures on data protection.1 Key highlights of these new measures include the following: A Bit of History China's journey toward a comprehensive pharmaceutical data protection framework has been ongoing for over two decades, a roller coaster ride from its […]
閱讀更多 >

Everything you need to know about Patent Term Adjustment (PTA) in China

2024年5月7日
We previously discussed patent term compensation for patent office delay (‘Patent Term Adjustment’ or ‘PTA’) when such new system was introduced in the Fourth Amendment of the Chinese Patent Law (2020), as well as in the different versions of the Draft Examination Guidelines released in 2021 and 2022. In this article, we consolidate everything you need to […]
閱讀更多 >
CN1982128B Figure

2019 CHINA TOP 10 IP CASE: VALEO V. LUCAS, FUKE, & CHEN

2020年6月8日
Every year in the spring The Supreme People’s Court of PRC announces its “Top 10 Intellectual Property (IP) cases” and “50 typical IP cases in Chinese courts” of the year. Although not having precedential weight, these cases serve as a reference and guide people's courts at all levels regarding their intellectual property trials. It’s always […]
閱讀更多 >
Top crossarrow-right